跳至主要内容
临床试验/NCT07426393
NCT07426393已完成不适用

Comparisons of Efficacy of Triphala and Chlorhexidine Mouthwash Against Plaque Accumulation and Gingivitis. A Randomized Controlled Trail.

Bangladesh Medical University1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2025年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
1
主要终点
PIaque Index

研究概览

简要总结

Gingivitis is one of the commonly prevalent oral diseases worldwide which is caused by the bacterial biofilm adhering to the teeth surfaces. Chlorhexidine is the antimicrobial agent most familiar to dental professionals. The need for frequent application of Chlorhexidine and other side effects such as unpleasant taste and staining has stimulated the search for alternatives. "Triphala" is among the most common formulas used in Traditional Ayurvedic Medicine. Triphala has an antibacterial effect. In this context, a study was undertaken to ascertain the effects of a mouthwash prepared with Triphala on the oral health status and compare it with commercially available Chlorhexidine mouthwash.

详细描述

Dental plaque is the main cause of gingivitis and effective plaque control is essential for maintaining gingival health. Along with mechanical cleaning methods, mouthwashes are commonly used as adjunct therapy to reduce plaque accumulation and gingival inflammation. Chlorhexidine is considered the gold standard chemical plaque control agent but its long-term use is limited by side effects such as tooth staining and taste alteration. Triphala, a herbal formulation with known antimicrobial and anti-inflammatory properties has emerged as a potential alternative. Comparing the efficacy of triphala and chlorhexidine mouthwash against plaque accumulation and gingivitis may help to identify a safer and acceptable option for maintaining routine oral hygiene.

Aims and objectives:

To compare the efficacy of triphala and chlorhexidine mouth wash against plaque accumulation and gingivitis.

Materials and methods

A randomized controlled trial was conducted among 220 patients with chronic generalized gingivitis attending the Outpatient Department of Bangladesh medical University (BMU), Dhaka. Participants were randomly assigned using shuffled numbered cards to Group A (Triphala mouthwash, n = 110) and Group B (Chlorhexidine mouthwash, n = 110).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age groups of 18-45 years with
  • Mild to moderate gingivitis,
  • Patients with a minimum of 20 teeth, and
  • Patients who have not undergone periodontal treatment in the past 6 months.

排除标准

  • Use of anti-inflammatory drugs and antibiotics in previous 6 months;
  • Individuals with prosthetic appliances or orthodontic appliances that would interfere with evaluation
  • Allergy to Triphala and Chlorhexidine used in the study;
  • Smokers or users of tobacco in any form
  • Lactating females or pregnant women
  • Mental-retarded patients.

研究组 & 干预措施

6% Triphala mouthwash

Experimental

Experimental: 15ml of 6%Triphala mouthwash twice daily for 30 days.

干预措施: 6% Triphala mouthwash (Other)

placebo Comparator:Placebo Participants received 15 ml of 6% chlorhexidine mouthwash

Placebo Comparator

placebo Participants received 15 ml mouthwash twice daily for 30 days

干预措施: .2% chlorhexidine mouthwash (Other)

结局指标

主要结局

PIaque Index

时间窗: 30 days

plaque index 0:no plaque is in the area adjacent to the gingiva plaque index 1:there is a plaque in the form of a thin film on the gingival margin plaque index 2:there is a visible plaque in the gingival pocket and gingival margin plaque index 3:there is a dense plaque in the gingival pocket and gingival margin

Gingival Index

时间窗: 30 days

Gingival index 0: Healthy gums. Gingival index 1: Mild discolouration and oedematous gingiva. No bleeding on probing. Gingival index 2: Red, oedematous and shiny gingiva. There is bleeding on probing. Gingival index 3: Red, oedematous and ulcerated gingiva. There is spontaneous bleeding.

BIeeding Index

时间窗: 30 days

次要结局

未报告次要终点

研究者

发起方
Bangladesh Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dilruba Sarmin

Principal investigator

Bangladesh Medical University

研究点 (1)

Loading locations...

相似试验